Related Experiment Video
Updated: Feb 12, 2026

A Tailored HPLC Purification Protocol That Yields High-purity Amyloid Beta 42 and Amyloid Beta 40 Peptides, Capable of Oligomer Formation
Published on: March 27, 2017
Amyloid-β Peptide Induces Prion Protein Amyloid Formation: Evidence for Its Widespread Amyloidogenic Effect
1The United Graduate School of Drug Discovery and Medical Information Sciences, Gifu University, 1-1 Yanagido, Gifu, 501-1194, Japan.
Abstract:
Transmissible spongiform encephalopathy is associated with misfolding of prion protein (PrP) into an amyloid β-rich aggregate. Previous studies have indicated that PrP interacts with Alzheimer's disease amyloid-β peptide (Aβ), but it remains elusive how this interaction impacts on the misfolding of PrP. This study presents the first in vitro evidence that Aβ induces PrP-amyloid formation at submicromolar concentrations. Interestingly, systematic mutagenesis of PrP revealed that Aβ requires no specific amino acid sequences in PrP, and induces the misfolding of other unrelated proteins (insulin and lysozyme) into amyloid fibrils in a manner analogous to PrP. This unanticipated nonspecific amyloidogenic effect of Aβ indicates that this peptide might be involved in widespread protein aggregation, regardless of the amino acid sequences of target proteins, and exacerbate the pathology of many neurodegenerative diseases.
Insights
Alzheimer's amyloid-beta (Aβ) peptide induces prion protein (PrP) misfolding into amyloid aggregates. This study shows Aβ can cause widespread, nonspecific protein aggregation, potentially worsening neurodegenerative diseases.
Area of Science:
- Neuroscience
- Biochemistry
- Protein Misfolding Diseases
Background:
- Transmissible spongiform encephalopathy is linked to prion protein (PrP) misfolding into amyloid aggregates.
- The interaction between PrP and Alzheimer's disease amyloid-beta peptide (Aβ) and its effect on PrP misfolding is not well understood.
Purpose of the Study:
- To investigate the in vitro effect of Aβ on PrP misfolding.
- To determine if Aβ's effect on PrP is sequence-specific.
- To explore Aβ's potential role in general protein aggregation.
Main Methods:
- In vitro assays to observe Aβ-induced PrP amyloid formation.
- Systematic mutagenesis of PrP to identify critical sequences for Aβ interaction.
- Testing Aβ's effect on other unrelated proteins (insulin, lysozyme) to assess amyloidogenic potential.
Main Results:
- Aβ induces PrP-amyloid formation at submicromolar concentrations.
- Aβ does not require specific amino acid sequences in PrP for this effect.
- Aβ induces amyloid fibril formation in unrelated proteins like insulin and lysozyme.
Conclusions:
- Aβ has a nonspecific amyloidogenic effect, promoting misfolding of various proteins.
- This mechanism suggests Aβ may contribute to widespread protein aggregation in neurodegenerative diseases.
- Aβ could exacerbate the pathology of multiple protein misfolding disorders beyond Alzheimer's disease.
More Related Videos
Related Concept Videos
Amyloid Fibrils
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
Amyloid Fibrils
The Evidence for Evolution
Protein and Protein Structure
A protein's shape is critical to its function. For example, an enzyme...
Peptide Bonds
Multi-pass Transmembrane Proteins and β-barrels
α-Helix containing multi-pass transmembrane proteins
Multi-pass transmembrane proteins such as...

